NAD+ Metabolite Links Cell's Translation Machine to Metabolic Stress Sensor
Scientists discover how ADP-ribose physically bridges two key enzymes, coupling NAD+ metabolism to protein synthesis under oxidative stress.
Summary
Researchers at Scripps Research have uncovered a direct molecular connection between NAD+ metabolism and protein synthesis. Using cryo-electron microscopy, they showed that ADP-ribose — a breakdown product of NAD+ — acts as a physical bridge between two enzymes: SerRS, which helps build proteins, and SIRT2, a sirtuin deacetylase tied to aging and stress responses. When these two enzymes bind together, each suppresses the other's activity. Under oxidative stress, a signaling pathway involving PARP1 increases ADP-ribose levels, promoting this interaction. This creates a feedback system where the cell can sense metabolic distress and simultaneously dial back both protein production and sirtuin activity. The mechanism appears conserved across vertebrates, suggesting broad biological relevance and potential implications for aging research.
Detailed Summary
The coordination between a cell's energy metabolism and its protein-making machinery is fundamental to survival, yet the molecular bridges connecting these systems remain poorly understood. This discovery adds a concrete new link with direct relevance to aging biology, where both NAD+ metabolism and translational control are central players.
Researchers at The Scripps Research Institute used cryo-electron microscopy to resolve the structure of human cytosolic seryl-tRNA synthetase (SerRS) bound to SIRT2, a sirtuin deacetylase implicated in aging, neurodegeneration, and metabolic regulation. The key enabler of this interaction is ADP-ribose (ADPR), a metabolite produced during NAD+ consumption, which acts as a molecular bridge between the two proteins.
The functional consequences are mutually inhibitory. When bound together, SIRT2's deacetylase activity is blocked because substrate access to its active site is obstructed. Simultaneously, SerRS's ability to charge transfer RNA with serine — a required step in protein synthesis — is suppressed because tRNA can no longer bind. Interestingly, tRNA itself attenuates the interaction, while ADPR strengthens it, creating a dynamic regulatory switch.
Critically, oxidative stress drives this interaction through a PARP1-dependent pathway. PARP1 consumes NAD+ and generates ADPR, meaning that when cells are under metabolic or oxidative stress, rising ADPR levels physically enforce a slowdown of both sirtuin signaling and protein translation simultaneously. This is a previously unappreciated regulatory node linking NAD+ status to translational output.
For longevity science, this matters because NAD+ levels decline with age and SIRT2 is a known longevity-associated enzyme. Understanding how ADPR modulates sirtuin activity adds nuance to NAD+ supplementation strategies. Limitations include that this is a structural and biochemical study conducted in vitro, with no direct in vivo aging or longevity outcomes reported.
Key Findings
- ADP-ribose physically bridges SerRS and SIRT2, creating a metabolite-gated regulatory complex.
- Complex formation mutually inhibits both SIRT2 deacetylase and SerRS aminoacylation activities.
- Oxidative stress promotes the interaction via PARP1, linking NAD+ consumption to translation slowdown.
- tRNA competes with ADPR to attenuate the complex, providing dynamic on/off control.
- The regulatory mechanism is likely conserved across all vertebrates.
Methodology
The team used cryo-electron microscopy to resolve the three-dimensional structure of the SerRS–SIRT2 complex. Biochemical assays were performed to characterize mutual inhibition of enzymatic activities and the roles of ADPR, tRNA, and K414 acetylation. PARP1-dependent oxidative stress signaling was probed to establish physiological context.
Study Limitations
This summary is based on the abstract only, as the full text was not available. The study is primarily structural and in vitro biochemical, with no direct in vivo data on aging or disease models reported in the abstract. Functional relevance in living organisms and therapeutic applicability remain to be established.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: